ES2052977T3 - Composicion que contiene bismuto. - Google Patents

Composicion que contiene bismuto.

Info

Publication number
ES2052977T3
ES2052977T3 ES90100737T ES90100737T ES2052977T3 ES 2052977 T3 ES2052977 T3 ES 2052977T3 ES 90100737 T ES90100737 T ES 90100737T ES 90100737 T ES90100737 T ES 90100737T ES 2052977 T3 ES2052977 T3 ES 2052977T3
Authority
ES
Spain
Prior art keywords
bismute
composition containing
product
aqueous solution
ulceric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90100737T
Other languages
English (en)
Inventor
Diego Furlan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euroresearch SRL
Original Assignee
Euroresearch SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroresearch SRL filed Critical Euroresearch SRL
Application granted granted Critical
Publication of ES2052977T3 publication Critical patent/ES2052977T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN PRODUCTO QUE CONTIENE BISMUTO DE FORMA QUE ES FACILMENTE DISPERSABLE EN AGUA PARA FORMAR UNA SOLUCION COLOIDAL UTIL PARA LA ADMINISTRACION ORAL COMO UNA MEDICINA ANTI-ULCERICA, SE OBTIENE DE UNA SOLUCION ACUOSA DE CITRATO DE POTASIO, CITRATO DE BISMUTO Y HIDROXIDO DE POTASIO. EL PRODUCTO SE PRECIPITA DESDE LA SOLUCION ACUOSA POR MEDIO DE DILUIRLA CON ACETONA.
ES90100737T 1989-01-25 1990-01-15 Composicion que contiene bismuto. Expired - Lifetime ES2052977T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919172A IT1229502B (it) 1989-01-25 1989-01-25 Composizioni contenenti bismuto idonee per uso terapeutico.

Publications (1)

Publication Number Publication Date
ES2052977T3 true ES2052977T3 (es) 1994-07-16

Family

ID=11155495

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90100737T Expired - Lifetime ES2052977T3 (es) 1989-01-25 1990-01-15 Composicion que contiene bismuto.

Country Status (10)

Country Link
US (1) US4965382A (es)
EP (1) EP0380950B1 (es)
JP (1) JPH02262534A (es)
AT (1) ATE84214T1 (es)
CA (1) CA2008068A1 (es)
DE (1) DE69000713T2 (es)
DK (1) DK0380950T3 (es)
ES (1) ES2052977T3 (es)
GR (1) GR3006752T3 (es)
IT (1) IT1229502B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
CN1055865C (zh) * 1995-10-30 2000-08-30 吴祁荃 X线结肠专用双对比造影剂
US6482865B1 (en) * 2000-04-12 2002-11-19 Gastropal Partners Method for preparing colloidal solution of bismuth sodium tartrate
US6699912B2 (en) * 2000-04-12 2004-03-02 Gastropal Partners Method for preparing colloidal solution of bismuth sodium tartrate
RU2416571C1 (ru) * 2010-02-15 2011-04-20 Учреждение Российской академии наук Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмута цитрата
RU2496719C1 (ru) * 2012-02-17 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут калий цитрата
RU2570610C1 (ru) * 2014-10-02 2015-12-10 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут аммоний цитрата
CN106632172A (zh) * 2016-12-28 2017-05-10 李玉成 枸橼酸抗坏血酸铋钾及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1536711A (en) * 1924-10-17 1925-05-05 Farbenfab Vorm Bayer F & Co Complex sodium bismuth salt of triglycollamic acid
US1663201A (en) * 1926-05-28 1928-03-20 Searle & Co Process for making bismuth tartrates and product produced thereby
US2054731A (en) * 1934-01-02 1936-09-15 Boots Pure Drug Co Ltd Organic salts of bismuth and process for producing same
US2232411A (en) * 1937-05-15 1941-02-18 George A Breon & Company Inc Bismuth hydroxylates of polyhydroxydicarboxylic acid salts
US2348984A (en) * 1942-06-25 1944-05-16 Robert A Lehman Sodium bismuth triglycollamate
US3840575A (en) * 1972-08-03 1974-10-08 Shirley Atkins Macclaren Bismuth subcompounds and their methods of preparation
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
ATE67669T1 (de) * 1988-10-08 1991-10-15 Pfleger R Chem Fab Fluessiges, wismuthaltiges arzneipraeparat, verfahren zum herstellen desselben und seine verwendung.

Also Published As

Publication number Publication date
JPH02262534A (ja) 1990-10-25
US4965382A (en) 1990-10-23
EP0380950B1 (en) 1993-01-07
GR3006752T3 (es) 1993-06-30
CA2008068A1 (en) 1990-07-25
ATE84214T1 (de) 1993-01-15
DK0380950T3 (da) 1993-02-08
EP0380950A2 (en) 1990-08-08
EP0380950A3 (en) 1990-12-27
DE69000713D1 (de) 1993-02-18
DE69000713T2 (de) 1993-05-06
IT1229502B (it) 1991-09-03
IT8919172A0 (it) 1989-01-25

Similar Documents

Publication Publication Date Title
ES2052977T3 (es) Composicion que contiene bismuto.
BRPI9811803B8 (pt) comprimido multiparticular aperfeiçoado de dissolução rápida
AU582920B2 (en) Continuous release pharmaceutical compositions
DK1267891T3 (da) Antiadhæsive carbonhydrater
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
BR9902457A (pt) Padrões de adesivo aperfeiçoados para artigos de higiene feminina.
EP0601619A3 (en) Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization.
AR020051A1 (es) Procedimiento de uso y uso de una combinacion de un anticuerpo anti-erbb2 y un agente quimicoterapeutico distinto de un derivado de antraciclina para la manufactura de un medicamento util para el tratamiento de cancer
TR200103606T2 (tr) Laktik Asit Bakterisi Kombinasyonu ve Kullanımı
ATE80294T1 (de) Injizierbare, opazifizierende liposomzusammensetzung.
BR9910251A (pt) Estimulação hematopoiética
GR76810B (es)
MY130441A (en) Solutions containing epinastin
DE60114249D1 (de) Pharmazeutische zusammensetzung mit 2-(4-isobutylphenyl) propionsäure
MX9205448A (es) Indicador visual sanitario.
ES2051235B1 (es) Producto de limpieza abrasivo acuoso, denso, con estabilidad coloidal mejorada.
PE20010127A1 (es) Suspension de ziprasidona
ES2076890B1 (es) Suplemento de pienso de sal de acido graso desodorizada.
ES2105961B1 (es) Procedimiento para la preparacion y purificacion de agentes de contraste yodados.
DE60006788D1 (de) Iod-herstellungszusammensetzung
ES8401848A1 (es) Procedimiento de obtencion de una composicion para la higiene intima femenina, especialmente para duchas vaginales.
ES2032393T3 (es) Metodo para producir un preparado acuoso.
ES2043900T3 (es) Conjugados de haptenos y proteinas y su utilizacion.
ES2032215T3 (es) Preparacion de isotiazolonas.
ATE203903T1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 380950

Country of ref document: ES